Evidence map›Paper›PMID 39994000›Full record

ArticleThoracic cancer2025

Comparison of Various GAN-Based Bone Suppression Imaging for High-Accurate Markerless Motion Tracking of Lung Tumors in CyberKnife Treatment.

Zennosuke Mochizuki, Masahide Saito, Toshihiro Suzuki, Koji Mochizuki, Hikaru Nemoto, Hiroshi Onishi, Hiroshi Takahashi

Abstract readComparative Study
In one paragraph

Article in Thoracic cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zennosuke MochizukiDepartment of Radiology, Kasugai General Rehabilitation Hospital, Yamanashi, Japan.ORCID https://orcid.org/0000-0002-5146-3158
Masahide SaitoDepartment of Radiology, University of Yamanashi, Chuo, Japan.ORCID https://orcid.org/0000-0002-8636-4045
Toshihiro SuzukiDepartment of Radiology, Kasugai General Rehabilitation Hospital, Yamanashi, Japan.
Koji MochizukiDepartment of Radiology, Kasugai General Rehabilitation Hospital, Yamanashi, Japan.
Hikaru NemotoDepartment of Radiology, University of Yamanashi, Chuo, Japan.
Hiroshi OnishiDepartment of Radiology, University of Yamanashi, Chuo, Japan.
Hiroshi TakahashiDepartment of Radiology, Kasugai General Rehabilitation Hospital, Yamanashi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stereotactic body radiation therapy (SBRT) is a highly effective treatment for lung cancer; however, challenges arise from tumor motion induced by respiration. The CyberKnife system, incorporating both fiducial-based and fiducial-free tracking modalities, aims to mitigate these challenges, yet tumor recognition can be compromised by overlapping bone structures. This study introduces a novel bone suppression imaging technique for kilovolt X-ray imaging using generative adversarial networks (GANs) to enhance tumor tracking in SBRT by reducing interference from bony structures. Computed tomography (CT) images, both with and without bone structures, were generated using a four-dimensional extended cardiac-torso phantom (XCAT phantom) across 56 cases. X-ray projections were captured from left and right oblique 45° angles and divided into nine segments, producing 1120 images. These images were processed through six pre-trained GAN models-CycleGAN, DualGAN, CUT, FastCUT, DCLGAN, and SimDCL-yielding bone-suppressed images on the XCAT phantom (BSI

Indexed as

Lung NeoplasmsRadiosurgeryTomography, X-Ray ComputedHumansPhantoms, Imagingdeep learninggenerative adversarial networks (GANs)lung cancerradiotherapystereotactic radiotherapy

Identifiers

PMID39994000
PMCPMC11850088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.